Mechanistic analysis showed that the improved prognosis of SCLC patients in the TGBF-HIGH group was associated with increased STING-mediated type I IFN secretion, enhanced antitumor immunity, reduced DNA damage repair, and enhanced apoptosis. Here, STING1 is linked to small cell lung carcinoma.